BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 31277631)

  • 1. Identifying risk factors of recurrence for clinically node negative papillary thyroid carcinoma with pathologic N1a.
    Ryu YJ; Cho JS; Park MH; Yoon JH
    BMC Surg; 2019 Jul; 19(1):78. PubMed ID: 31277631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying risk factors of lateral lymph node recurrence in clinically node-negative papillary thyroid cancer.
    Ryu YJ; Kang SJ; Cho JS; Yoon JH; Park MH
    Medicine (Baltimore); 2018 Dec; 97(51):e13435. PubMed ID: 30572443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying risk factors for recurrence of papillary thyroid cancer in patients who underwent modified radical neck dissection.
    Ryu YJ; Cho JS; Yoon JH; Park MH
    World J Surg Oncol; 2018 Oct; 16(1):205. PubMed ID: 30314503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nodal Factors Predictive of Recurrence After Thyroidectomy and Neck Dissection for Papillary Thyroid Carcinoma.
    Nam SH; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Thyroid; 2018 Jan; 28(1):88-95. PubMed ID: 29117854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
    Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
    Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
    Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
    Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic lymph node dissection in papillary thyroid carcinoma: is there a place for lateral neck dissection?
    Ducoudray R; Trésallet C; Godiris-Petit G; Tissier F; Leenhardt L; Menegaux F
    World J Surg; 2013 Jul; 37(7):1584-91. PubMed ID: 23564213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors for Recurrence After Treatment of N1b Papillary Thyroid Carcinoma.
    Lee SH; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Ann Surg; 2019 May; 269(5):966-971. PubMed ID: 29462007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of multifocality in papillary thyroid carcinoma.
    Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors for Lateral Neck Recurrence of N0/N1a Papillary Thyroid Cancer.
    Kim Y; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Ann Surg Oncol; 2017 Nov; 24(12):3609-3616. PubMed ID: 28822118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central lymph node metastasis of unilateral papillary thyroid carcinoma: patterns and factors predictive of nodal metastasis, morbidity, and recurrence.
    Roh JL; Kim JM; Park CI
    Ann Surg Oncol; 2011 Aug; 18(8):2245-50. PubMed ID: 21327454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lateral lymph node recurrence after total thyroidectomy and central neck dissection in patients with papillary thyroid cancer without clinical evidence of lateral neck metastasis.
    Lim YC; Liu L; Chang JW; Koo BS
    Oral Oncol; 2016 Nov; 62():109-113. PubMed ID: 27865362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node ratio predicts recurrence in pediatric papillary thyroid cancer.
    Rubinstein JC; Dinauer C; Herrick-Reynolds K; Morotti R; Callender GG; Christison-Lagay ER
    J Pediatr Surg; 2019 Jan; 54(1):129-132. PubMed ID: 30361076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic lymphocytic thyroiditis protects against recurrence in patients with cN0 papillary thyroid cancer.
    Ryu YJ; Yoon JH
    Surg Oncol; 2020 Sep; 34():67-73. PubMed ID: 32891356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
    Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
    Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of Patients with 1-4 cm Papillary Thyroid Cancer Who Underwent Lobectomy: Focus on Gross Extrathyroidal Extension Invading Only the Strap Muscles.
    Jang A; Jin M; Kim WW; Jeon MJ; Sung TY; Song DE; Kim TY; Chung KW; Kim WB; Shong YK; Lee YM; Kim WG
    Ann Surg Oncol; 2022 Nov; 29(12):7835-7842. PubMed ID: 35907995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph node ratio of the central compartment is a significant predictor for locoregional recurrence after prophylactic central neck dissection in patients with thyroid papillary carcinoma.
    Ryu IS; Song CI; Choi SH; Roh JL; Nam SY; Kim SY
    Ann Surg Oncol; 2014 Jan; 21(1):277-83. PubMed ID: 24006096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperative diagnosis of central compartment lymph node metastasis predicts recurrence of patients with papillary thyroid carcinoma and clinically node-negative lateral neck and may guide extent of initial surgery.
    Lee CW; Gong G; Roh JL
    World J Surg; 2015 Jan; 39(1):194-202. PubMed ID: 25234198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive Factors of Central-Compartment Lymph Node Metastasis for Clinical N0 Papillary Thyroid Carcinoma With Strap Muscle Invasion.
    Xue S; Zhang L; Pang R; Wang P; Jin M; Guo L; Zhou Y; Dong B; Chen G
    Front Endocrinol (Lausanne); 2020; 11():511. PubMed ID: 33013682
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 33.